Stroke Clinical Trials

Find Stroke Clinical Trials Near You

Late-Onset Seizures: Trial of Vascular Risk Investigation and Treatment

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

A growing body of evidence suggests patients with late-onset seizures are at an increased risk of stroke, but the potential for reducing cardiovascular morbidity through risk factor screening and management is unknown. The investigators aim to determine whether individuals with new-onset unprovoked seizures after middle age should undergo vascular risk assessment. In a cluster project the investigators assess the effect of vascular risk factor screening in an observational study as well as a cohort study. The project has two interlinked components: a prospective single group study, in which risk factor assessment is performed and subsequent management is followed for one year; and a register-based cohort study examining the long-term effects of the intervention on a system level.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Healthy Volunteers: f
View:

⁃ Clinical study:

⁃ \- First assessment for unprovoked seizures or epilepsy with onset after age 50 -- - vascular risk factor evaluation per the new routine at participating care givers

⁃ Register study:

• age ≥50 with a first-ever outpatient appointment to one of the participating clinics and

• a first-listed diagnostic code for seizures or epilepsy (ICD-10: R568, G40)

Locations
Other Locations
Sweden
Södra Älvsborg Sjukhus
RECRUITING
Borås
Salgrenska University Hospital
RECRUITING
Gothenburg
Skånes universitetssjukhus
RECRUITING
Malmo
Contact Information
Primary
Johan Zelano, MD PhD
johan.zelano@neuro.gu.se
+46313421000
Backup
David Larson, MD PhD
david.gw.larsson@vgregion.se
+46313421000
Time Frame
Start Date: 2025-09-01
Estimated Completion Date: 2035-06
Participants
Target number of participants: 420
Treatments
First seizure after age 50
All patients evaluated for a first seizure after age 50 at the providers.
Sponsors
Collaborators: Uppsala University Hospital, Danderyd Hospital, Sodra Alvsborgs Hospital, Skane University Hospital
Leads: Sahlgrenska University Hospital

This content was sourced from clinicaltrials.gov